Skip to main content

A New Era: Understanding Lecanemab, Donameb, and Emerging Therapies for Alzheimer's Disease

Join us for a FREE interactive webinar with an inter-professional panel of experts to answer questions you have about the newly approved and emerging therapies for Alzheimer's disease (e.g., lecanemab, donanemab).

Monday, November 6, 2023, from 11:00am - 12:30pm EST.

Register today.